These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 30070315)
1. Expression and correlation of MMP-9, VEGF, and p16 in infantile hemangioma. Yin RR; Hao D; Chen P Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4806-4811. PubMed ID: 30070315 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Kleinman ME; Greives MR; Churgin SS; Blechman KM; Chang EI; Ceradini DJ; Tepper OM; Gurtner GC Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2664-70. PubMed ID: 17872454 [TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis. Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of plasma and urinary levels of vascular endothelial growth factor and matrix metalloproteinase-9 in patients with infantile hemangioma. Rotter A; Lima XT; Oliveira ZNP Int J Dermatol; 2021 Oct; 60(10):1263-1269. PubMed ID: 33959962 [TBL] [Abstract][Full Text] [Related]
5. Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma. Wen YL; Li L Genet Mol Res; 2015 Dec; 14(4):19342-8. PubMed ID: 26782587 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Munaut C; Noël A; Hougrand O; Foidart JM; Boniver J; Deprez M Int J Cancer; 2003 Oct; 106(6):848-55. PubMed ID: 12918061 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy. Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G Mol Vis; 2018; 24():394-406. PubMed ID: 29853773 [TBL] [Abstract][Full Text] [Related]
9. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer. Lu CL; Ji Y; Ge D; Guo J; Ding JY Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342 [TBL] [Abstract][Full Text] [Related]
10. [The change of serum vascular endothelial growth factor and matrix metalloproteinases-9 in proliferative hemangioma treated with propranolol]. Zhao ZF; Lü RR; Huo R; Fu HB; Xu GQ Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Sep; 27(5):359-61. PubMed ID: 22259987 [TBL] [Abstract][Full Text] [Related]
11. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Adya R; Tan BK; Punn A; Chen J; Randeva HS Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986 [TBL] [Abstract][Full Text] [Related]
13. [The relationship of MMP-9, VEGF and PCNA expressions and their clinical significance in gastric adenocarcinoma]. Zhao FJ; Kang CS; Cui XW; Song XM; Liu J; Zhang QY Zhonghua Nei Ke Za Zhi; 2009 Feb; 48(2):114-7. PubMed ID: 19549464 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-α expressions in colorectal cancer. Araújo RF; Lira GA; Vilaça JA; Guedes HG; Leitão MC; Lucena HF; Ramos CC Pathol Res Pract; 2015 Jan; 211(1):71-7. PubMed ID: 25446246 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer. Jobim FC; Xavier NL; Uchoa DM; Cruz DB; Saciloto M; Chemello N; Schwartsmann G Braz J Med Biol Res; 2009 Oct; 42(10):979-87. PubMed ID: 19787153 [TBL] [Abstract][Full Text] [Related]
16. Propranolol inhibits proliferation and invasion of hemangioma-derived endothelial cells by suppressing the DLL4/Notch1/Akt pathway. Sun B; Dong C; Lei H; Gong Y; Li M; Zhang Y; Zhang H; Sun L Chem Biol Interact; 2018 Oct; 294():28-33. PubMed ID: 30130526 [TBL] [Abstract][Full Text] [Related]
17. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face. Tokuyama W; Mikami T; Masuzawa M; Okayasu I Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279 [TBL] [Abstract][Full Text] [Related]
18. Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor. Lou G; Gao Y; Ning XM; Zhang QF World J Gastroenterol; 2005 Aug; 11(32):5032-6. PubMed ID: 16124061 [TBL] [Abstract][Full Text] [Related]
19. The pigment epithelium-derived factor (PEDF): an important potential therapeutic agent for infantile hemangioma. Li M; Chen Y; Guo Z; Xie Y; Zhou Y; Jiang C; Chen X Arch Dermatol Res; 2017 Apr; 309(3):169-178. PubMed ID: 28197761 [TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma]. Zhong C; Guo RP; Shi M; Wei W; Yu WS; Li JQ Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]